Clinical Trials in Tennessee

Showing 17661-17680 of 20,239 trials

Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors

NCT00827177

This is an open-label, dose-escalation study of ARQ 197 administered orally in combination with sorafenib.

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)87 participantsStarted Sep 2009

Boston, Massachusetts, United States • Buffalo, New York, United States • Nashville, Tennessee, United States +1 more locations

UNKNOWNPhase 229 miles

Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

NCT00301990

RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Bevacizumab may also stop the growth of tumor cells by blocking blood flow to the tumor. Interleukin-2 may stimulate the white blood cells to kill tumor cells. Giving bevacizumab together with interleukin-2 may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving bevacizumab together with interleukin-2 works in treating patients with metastatic kidney cancer.

Kidney Cancer

Jonsson Comprehensive Cancer Center65 participantsStarted Sep 2005

Los Angeles, California, United States • Maywood, Illinois, United States • Indianapolis, Indiana, United States +8 more locations

Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors

Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Find Trials by Condition in Tennessee

Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer

Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive

Diabetes and Periodontal Therapy Trial

Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With Hypertension

Study to Evaluate the Prospective Payment System

Kidney and Liver Transplantation in People With HIV

Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney

Dose Finding Study of Gadavist in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection

Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination

Clinical Evaluation of the Crosstrees Pod™ in the Treatment of Pathologic Fracture of the Vertebral Body (Levels T4 - L5) in Adult Patients

Youth Partners in Care: Depression and Quality Improvement

A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer

TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch

A Comparison of Air Insufflation, Water Immersion and Water Exchange Colonoscopy in CRC Screening